Sc&H Financial Advisors, Inc. Bristol Myers Squibb CO Transaction History

Sc&H Financial Advisors, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 01, 2024	SELL	$48.48 - $57.85 $121,296 - $144,740	-2,502 Reduced 36.92%	4,274 $219,000
Q2 2023 Aug 07, 2023	SELL	$63.71 - $70.74 $9,620 - $10,681	-151 Reduced 2.18%	6,776 $433,000
Q1 2023 May 12, 2023	BUY	$65.71 - $74.53 $54,867 - $62,232	835 Added 13.71%	6,927 $480,000
Q4 2022 Feb 10, 2023	SELL	$68.48 - $81.09 $17,120 - $20,272	-250 Reduced 3.94%	6,092 $438,000
Q3 2022 Nov 09, 2022	SELL	$0.13 - $76.84 $232 - $137,620	-1,791 Reduced 22.02%	6,342 $451,000
Q2 2022 Aug 10, 2022	SELL	$72.62 - $79.98 $10,312 - $11,357	-142 Reduced 1.72%	8,133 $626,000
Q1 2022 May 10, 2022	BUY	$61.48 - $73.72 $15,738 - $18,872	256 Added 3.19%	8,275 $604,000
Q4 2021 Feb 10, 2022	BUY	$53.63 - $62.52 $430,058 - $501,347	8,019 New	8,019 $500,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Sc&H Financial Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Sc&H Financial Advisors, Inc. with notifications on news.